- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Lymphoma Heavyweights Launch New Partnership
The Leukemia & Lymphoma Society (LLS), the Lymphoma Research Foundation (LRF), CancerCare, the Association of Community Cancer Centers (ACCC) and Genentech have announced a new partnership in hopes of connecting the lymphoma community under one banner.
Together they have launched the "Alliance for Resource Collaboration in Hematology" (ARCH), found at www.LymphomaResources.com.
"Many people diagnosed with lymphoma, particularly in community cancer programs, are unaware of all the resources available to them," said Louis J. DeGennaro, Ph.D., LLS's president and chief executive officer. "With this new initiative, our goal is to empower people with lymphoma to be active partners in their care and ensure they don't feel isolated in their journey."
By visiting the website, people can connect to the partner organizations to learn about the different types of lymphoma, explore treatment options, find information about specialists and search financial support options. The ARCH website also helps people find patient communities, peer support programs and counseling services. The partner organizations provide these resources in a variety of formats, including in-person programs, online materials and telephone support.
It's estimated that only 15 percent of U.S. cancer patients are treated at the nation's major academic cancer centers. The vast majority receive care at cancer programs in or near their home communities, where resources may be more limited. By bringing together ACCC's network of community cancer programs with the quality resources provided by LLS, LRF and CancerCare, ARCH aims to make an immediate positive impact for lymphoma patients.
Source: PR Newswire